Literature DB >> 28584023

Notch Represses Transcription by PRC2 Recruitment to the Ternary Complex.

Xiaoqing Han1,2, Prathibha Ranganathan1,3, Christos Tzimas4, Kelly L Weaver1, Ke Jin1,2, Luisana Astudillo1, Wen Zhou1, Xiaoxia Zhu1, Bin Li1, David J Robbins1, Anthony J Capobianco5.   

Abstract

It is well established that Notch functions as a transcriptional activator through the formation of a ternary complex that comprises Notch, Maml, and CSL. This ternary complex then serves to recruit additional transcriptional cofactors that link to higher order transcriptional complexes. The mechanistic details of these events remain unclear. This report reveals that the Notch ternary complex can direct the formation of a repressor complex to terminate gene expression of select target genes. Herein, it is demonstrated that p19Arf and Klf4 are transcriptionally repressed in a Notch-dependent manner. Furthermore, results indicate that Notch recruits Polycomb Repressor Complex 2 (PRC2) and Lysine Demethylase 1 (KDM1A/LSD1) to these promoters, which leads to changes in the epigenetic landscape and repression of transcription. The demethylase activity of LSD1 is a prerequisite for Notch-mediated transcriptional repression. In addition, a stable Notch transcriptional repressor complex was identified containing LSD1, PRC2, and the Notch ternary complex. These findings demonstrate a novel function of Notch and provide further insight into the mechanisms of Notch-mediated tumorigenesis.Implications: This study provides rationale for the targeting of epigenetic enzymes to inhibit Notch activity or use in combinatorial therapy to provide a more profound therapeutic response. Mol Cancer Res; 15(9); 1173-83. ©2017 AACR. ©2017 American Association for Cancer Research.

Entities:  

Mesh:

Substances:

Year:  2017        PMID: 28584023      PMCID: PMC5581691          DOI: 10.1158/1541-7786.MCR-17-0241

Source DB:  PubMed          Journal:  Mol Cancer Res        ISSN: 1541-7786            Impact factor:   5.852


  50 in total

1.  Genome-wide profiling of PRC1 and PRC2 Polycomb chromatin binding in Drosophila melanogaster.

Authors:  Bas Tolhuis; Elzo de Wit; Inhua Muijrers; Hans Teunissen; Wendy Talhout; Bas van Steensel; Maarten van Lohuizen
Journal:  Nat Genet       Date:  2006-04-20       Impact factor: 38.330

2.  Transcriptional repression mediated by the human polycomb-group protein EED involves histone deacetylation.

Authors:  J van der Vlag; A P Otte
Journal:  Nat Genet       Date:  1999-12       Impact factor: 38.330

3.  Long noncoding RNA as modular scaffold of histone modification complexes.

Authors:  Miao-Chih Tsai; Ohad Manor; Yue Wan; Nima Mosammaparast; Jordon K Wang; Fei Lan; Yang Shi; Eran Segal; Howard Y Chang
Journal:  Science       Date:  2010-07-08       Impact factor: 47.728

Review 4.  Emerging properties of animal gene regulatory networks.

Authors:  Eric H Davidson
Journal:  Nature       Date:  2010-12-16       Impact factor: 49.962

5.  Kruppel-like factor 4 is acetylated by p300 and regulates gene transcription via modulation of histone acetylation.

Authors:  Paul M Evans; Wen Zhang; Xi Chen; Jun Yang; Kishor K Bhakat; Chunming Liu
Journal:  J Biol Chem       Date:  2007-10-01       Impact factor: 5.157

Review 6.  Targeting EZH2 in cancer.

Authors:  Kimberly H Kim; Charles W M Roberts
Journal:  Nat Med       Date:  2016-02       Impact factor: 53.440

Review 7.  The Polycomb complex PRC2 and its mark in life.

Authors:  Raphaël Margueron; Danny Reinberg
Journal:  Nature       Date:  2011-01-20       Impact factor: 49.962

8.  Fbw7 repression by hes5 creates a feedback loop that modulates Notch-mediated intestinal and neural stem cell fate decisions.

Authors:  Rocio Sancho; Sophia M Blake; Christian Tendeng; Bruce E Clurman; Julian Lewis; Axel Behrens
Journal:  PLoS Biol       Date:  2013-06-11       Impact factor: 8.029

Review 9.  Targeting histone methyltransferases and demethylases in clinical trials for cancer therapy.

Authors:  Ludovica Morera; Michael Lübbert; Manfred Jung
Journal:  Clin Epigenetics       Date:  2016-05-24       Impact factor: 6.551

Review 10.  From fly wings to targeted cancer therapies: a centennial for notch signaling.

Authors:  Panagiotis Ntziachristos; Jing Shan Lim; Julien Sage; Iannis Aifantis
Journal:  Cancer Cell       Date:  2014-03-17       Impact factor: 31.743

View more
  6 in total

1.  NACK and INTEGRATOR act coordinately to activate Notch-mediated transcription in tumorigenesis.

Authors:  Elena Shersher; Mohini Lahiry; Annamil Alvarez-Trotta; Giulia Diluvio; David J Robbins; Ramin Shiekhattar; Anthony J Capobianco
Journal:  Cell Commun Signal       Date:  2021-09-22       Impact factor: 7.525

Review 2.  Advances in Therapeutic Targeting of Cancer Stem Cells within the Tumor Microenvironment: An Updated Review.

Authors:  Kevin Dzobo; Dimakatso Alice Senthebane; Chelene Ganz; Nicholas Ekow Thomford; Ambroise Wonkam; Collet Dandara
Journal:  Cells       Date:  2020-08-13       Impact factor: 6.600

Review 3.  Non-Canonical Functions of the ARF Tumor Suppressor in Development and Tumorigenesis.

Authors:  Nefeli Lagopati; Konstantinos Belogiannis; Andriani Angelopoulou; Angelos Papaspyropoulos; Vassilis Gorgoulis
Journal:  Biomolecules       Date:  2021-01-12

Review 4.  The Role of Polycomb Repressive Complex in Malignant Peripheral Nerve Sheath Tumor.

Authors:  Xiyuan Zhang; Béga Murray; George Mo; Jack F Shern
Journal:  Genes (Basel)       Date:  2020-03-09       Impact factor: 4.096

5.  Genomic analyses of early responses to radiation inglioblastoma reveal new alterations at transcription,splicing, and translation levels.

Authors:  Saket Choudhary; Suzanne C Burns; Hoda Mirsafian; Wenzheng Li; Dat T Vo; Mei Qiao; Xiufen Lei; Andrew D Smith; Luiz O Penalva
Journal:  Sci Rep       Date:  2020-06-02       Impact factor: 4.379

6.  A NOTCH1/LSD1/BMP2 co-regulatory network mediated by miR-137 negatively regulates osteogenesis of human adipose-derived stem cells.

Authors:  Cong Fan; Xiaohan Ma; Yuejun Wang; Longwei Lv; Yuan Zhu; Hao Liu; Yunsong Liu
Journal:  Stem Cell Res Ther       Date:  2021-07-22       Impact factor: 6.832

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.